The Clorox Company $CLX Shares Bought by MB Levis & Associates LLC

MB Levis & Associates LLC raised its stake in The Clorox Company (NYSE:CLX) by 3.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,095 shares of the company’s stock after acquiring an additional 194 shares during the period. MB Levis & Associates LLC’s holdings in Clorox were worth $732,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also made changes to their positions in CLX. Hsbc Holdings PLC raised its holdings in shares of Clorox by 118.8% in the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after buying an additional 589,544 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its holdings in shares of Clorox by 101.8% in the second quarter. Robeco Institutional Asset Management B.V. now owns 1,083,723 shares of the company’s stock valued at $130,123,000 after buying an additional 546,761 shares during the last quarter. KBC Group NV raised its holdings in shares of Clorox by 688.7% in the first quarter. KBC Group NV now owns 587,679 shares of the company’s stock valued at $86,535,000 after buying an additional 513,171 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Clorox by 412.1% in the first quarter. AQR Capital Management LLC now owns 598,758 shares of the company’s stock valued at $88,167,000 after buying an additional 481,846 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Clorox by 147.6% in the first quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock valued at $104,107,000 after buying an additional 421,453 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.63% of the company’s stock.

Clorox Trading Up 1.8%

Shares of Clorox stock opened at $119.73 on Friday. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market cap of $14.58 billion, a PE ratio of 18.36, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The company has a 50-day moving average of $121.61 and a two-hundred day moving average of $127.73.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period last year, the company posted $1.82 earnings per share. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox’s dividend payout ratio (DPR) is 76.07%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CLX. Jefferies Financial Group reduced their target price on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a report on Thursday, June 26th. Citigroup cut their price target on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. The Goldman Sachs Group cut their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. Barclays cut their price target on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday, September 30th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and an average price target of $130.20.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.